D-1668-2012 Class II Terminated
FDA drug recall D-1668-2012 was initiated by American Health Packaging on Jul 23, 2012 and is designated Class II. Reason for recall: Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for… The recall status is terminated (terminated Feb 19, 2013). Affected quantity: 694 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 5, 2012
- Initiation Date
- Jul 23, 2012
- Termination Date
- Feb 19, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 694 cartons
Product description
Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, Packaged by American Health Packaging, 2550-A John Glenn Avenue, Columbus, OH 43217, barcode 6808432511; Carton labeling Dist by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977, NDC 68084-325-21.
Reason for recall
Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.
Distribution pattern
Nationwide.
Code information
Lot #: 120604 Exp 2/28/2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1668-2012
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026